Skip to content
value.today

Senores Pharmaceuticals Limited

SENORES.NS
$549 Mmarket cap on Nov 19, 2026
1D
+2.0%
Compare
World rank
#12,160
Revenue
—
annual
Net income
—
Employees
—

Senores Pharmaceuticals Limited in brief

Senores Pharmaceuticals Limited is a listed company in the Healthcare sector, based in India. Its market value was $549 M on 19 November 2026, which makes it the 12,160th largest listed company in the world and the 849th largest in India on this site. Its shares trade under the symbol SENORES.NS (NSE).

Written from the figures on this page, so it changes when they do. Dates and sources are under Sources and freshness.

Senores Pharmaceuticals Limited timeline

1 events, 2024
  1. 2024
  2. 📈
    Listed on National Stock Exchange of India as SENORES
    First day of listing in the exchange's official list.

Events of Senores Pharmaceuticals Limited from the exchanges' official lists. Dates marked approximate come from statements without a cited source. Spotted a mistake? Use the correction form below.

Senores Pharmaceuticals Limited share price · NSE (SENORES.NS)

daily · 467 trading days since 2024
Last close 1,113 INR (Nov 19, 2026)1 month: -11.2%1 year: +40.7%52-week range 706.00 – 1,599 INR
$0 M$419 M$837 M$1.3 B$1.7 B20252026
DateOpenHighLowCloseChangeVolume
Nov 19, 20261,0871,1251,0791,113+1.9%237,313
Nov 18, 20261,1391,1461,0831,093-4.0%406,925
Nov 17, 20261,1481,1651,1341,139-0.8%154,847
Nov 16, 20261,1751,1861,1431,148-2.3%139,529
Nov 13, 20261,2081,2271,1651,175-3.5%409,497
Nov 12, 20261,1731,2221,1731,217+3.7%202,580
Nov 11, 20261,1751,1871,1611,173-0.2%166,000
Nov 9, 20261,1991,2201,1701,175+1.2%155,540
Nov 6, 20261,1851,1851,1301,161-2.3%274,945
Nov 5, 20261,1431,2051,1361,188+4.5%348,940
Nov 4, 20261,1431,1551,1251,137-0.9%134,487
Nov 3, 20261,1151,1651,0961,147+2.4%347,256
Nov 2, 20261,1461,1521,0941,120-1.3%505,488
Oct 30, 20261,2191,2281,0531,134-7.0%2.3 M
Oct 29, 20261,3241,3401,2081,219-7.9%1.1 M
Oct 28, 20261,3151,3411,3101,324+1.0%186,875
Oct 27, 20261,2551,3181,2491,311+5.3%204,236
Oct 26, 20261,2201,2601,2101,246+2.5%158,092
Oct 23, 20261,2111,2211,1681,215+1.1%165,744
Oct 22, 20261,2021,2431,1951,203-1.8%182,678
Oct 21, 20261,2541,2551,1961,224-2.4%303,198
Oct 19, 20261,3241,3451,2411,254-4.9%249,045
Oct 16, 20261,2591,3241,2541,318+4.7%286,388
Oct 15, 20261,2811,2971,2541,259-1.8%159,308
Oct 14, 20261,3211,3251,2711,282-3.0%145,695
Oct 13, 20261,3191,3321,2871,321+0.2%168,254
Oct 12, 20261,3351,3491,3111,319-0.1%130,501
Oct 9, 20261,3291,3441,3061,320-0.4%141,415
Oct 8, 20261,3901,3931,3111,326-4.6%299,845
Oct 7, 20261,4001,4241,3801,390—197,473

Prices in INR from the National Stock Exchange of India; the last 30 trading days are listed, the chart shows up to ten years. For information only; not investment advice.

Senores Pharmaceuticals Limited share price statistics

computed nightly from the daily prices
NSE · SENORES.NSClose 1,113 INR (Nov 19, 2026)
1 day
+1.9%
1 week
-8.6%
1 month
-11.2%
3 months
-28.2%
Year to date
+35.4%
1 year
+40.7%
3 years
—
5 years
—
10 years
—
52-week low 706.00-30.4% from the highhigh 1,599
Highest on record 1,599 INR (Aug 24, 2026)Volume 328,436 shares/dayValue traded 392.4 M INR/dayVolatility 52% (30d), 43% (1y)467 trading days on record

Changes compare closing prices; volatility is the annualised standard deviation of daily returns. Prices are as published by the exchange, not adjusted for splits, bonus issues or dividends. For information only; not investment advice.

Market cap history

$0 M$161 M$322 M$483 M$644 M

World rank over time

▼ down 330 places since 2026
2026-11-12: #11829#11,82920262026-11-13: #12066#12,06620262026-11-16: #12094#12,09420262026-11-17: #12087#12,08720262026-11-18: #12254#12,25420262026-11-19: #12159#12,1592026

Rank in India: #817 (Nov 2026) · #838 (Nov 2026) · #840 (Nov 2026) · #843 (Nov 2026) · #853 (Nov 2026) · #849 (Nov 2026)

Mutual funds holding Senores Pharmaceuticals Limited#

5 funds in 2 countries hold shares worth $2 M. Since their previous reports 0 added shares and 1 sold, selling $0 M net. By country: USA 4 ($1 M), India 1 ($1 M).
Mutual funds holding Senores Pharmaceuticals Limited
FundSharesValueOf the companyOf the fundChange in sharesReport
🇺🇸 Avantis Emerging Markets Equity ETFAmerican Century ETF Trust68,854$1 M—<0.01%no changeMay 31, 2026
🇮🇳 Motilal Oswal Nifty Microcap 250 Index FundMotilal Oswal Asset Management59,410$1 M—0.31%−1.9%Oct 31, 2026
🇺🇸 State Street SPDR S&P Emerging Markets Small Cap ETFSSGA Funds Management, Inc.9,557$0 M—0.02%no changeJun 30, 2026
🇺🇸 VanEck India Growth Leaders ETFVan Eck Associates Corporation12,860$0 M—0.10%—Mar 31, 2026
🇺🇸 Avantis Emerging Markets ex-China Equity ETFAmerican Century ETF Trust2,054$0 M—<0.01%no changeMay 31, 2026

Source: Fund portfolio reports to the SEC (Form N-PORT), CVM, Finansinspektionen and Indian fund houses · as of Oct 31, 2026. The 5 largest positions, each from the fund's newest report; report dates differ between funds. A fund family's funds are listed one by one, so one manager can appear many times.

FDA drug approvals: Senores Pharmaceuticals Limited#

1 approved applications held; 1 approvals and 0 new uses in 2026.

Approvals held
1
New molecular entities
0
New uses approved
0
efficacy supplements
Generics
1
0 new drugs, 0 biologics
Senores Pharmaceuticals Limited: latest FDA approvals
ApprovedDrugKind
2026-10-26Propranolol HydrochloridePropranolol Hydrochloride · ANDA216072Generic drug (ANDA)

Source: Drugs@FDA (openFDA). Approvals are listed under the application's current holder (SENORES PHARMS), so they follow acquisitions

Discuss Senores Pharmaceuticals Limited#

1 automatic updates and 0 member comments. Sign in to comment and react.

  • Mutual funds: 5 funds hold $2 millionautomatic update · Oct 31, 2026

    5 mutual funds in 2 countries hold shares of Senores Pharmaceuticals Limited worth $2 million (funds' newest reports, up to 31 October 2026). Since their previous reports 0 funds added shares and 1 sold; on balance they sold $10,000. Share splits are not counted as trading.

How Senores Pharmaceuticals Limited compares in Healthcare

CompanyMarket capP/ENet marginRev. growth
Senores Pharmaceuticals Limited🇮🇳$549 M———
Eli Lilly and Company🇺🇸$1.20 T43.4×31.9%+44.7%
Johnson & Johnson🇺🇸$652.5 B40.5×16.2%+6.0%
AbbVie Inc.🇺🇸$514.0 B49.7×15.7%+8.6%
Roche Holding AG🇨🇭$370.3 B29.1×19.0%—
UnitedHealth Group Incorporated🇺🇸$367.7 B23.1×3.5%+11.8%
Merck & Co., Inc.🇺🇸$359.8 B146.7×3.6%+1.3%
Novartis AG🇨🇭$286.8 B20.5×24.7%—
Thermo Fisher Scientific Inc.🇺🇸$253.8 B35.9×14.9%+3.9%

P/E and margins use trailing 12-month results where available; growth is the latest fiscal year.

Questions, comparisons and similar companies#

Sources and freshness

Market cap:
Nov 19, 2026
Profile updated:
Nov 20, 2026

Figures from Market data, value.today research.

How each figure is collected: data sources and methodology. Market caps in US dollars unless you switch the currency.

Work at Senores Pharmaceuticals Limited? Verify and update this profile — free

Use your work e-mail address (on the company's own domain if possible). Fill in only what is new or missing; a link to where the figures are published (annual report, press release) speeds up the review.

Show Senores Pharmaceuticals Limited's ranking on your website Get the badge
Badge preview

The badge updates itself as the ranking changes.

Something wrong or missing about Senores Pharmaceuticals Limited? Suggest a correction